Table 1.
Patient no. | Sample type | Susceptibility (MIC, in μg/ml)b |
penA mutationc |
Allele no.d |
STe | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Penicillin | Tetracycline | Ceftriaxone | Cefixime | Ciprofloxacin | Azithromycin | I312M | V316T | G545S | por | tbpB | |||
1 | Urethra | 2 | 1 | 0.06 | 0.12 | >32 | 0.5 | M | T | S | 908 | 110 | 1407 |
2 | Urethra | 2 | 2 | 0.06 | 0.12 | ≥32 | 0.5 | M | T | S | 908 | 110 | 1407 |
3 | Urethra | 2 | 0.5 | 0.06 | 0.12 | ≥32 | 0.5 | M | T | S | 3669 | 110 | 6200 |
4 | Cervix | 2 | 0.5 | 0.06 | 0.12 | >32 | 0.5 | M | T | S | 2743 | 110 | 4461 |
5 | Urethra | 2 | 1 | 0.06 | 0.12 | 16 | 0.5 | M | T | S | 1914 | 110 | 3158 |
6 | Urethra | 2 | 1 | 0.06 | 0.12 | ≥32 | 0.5 | M | T | S | 908 | 110 | 1407 |
7 | Urethra | 0.25 | 0.25 | 0.016 | 0.06 | 4 | 0.06 | M | T | S | 908 | 110 | 1407 |
8 | Cervix | 0.25 | 0.12 | 0.25 | ≤0.016 | ≥32 | 0.25 | I | V | G | 1910 | 27 | 4637 |
9 | Urethra | 0.5 | 1 | 0.016 | ≤0.016 | 8 | 0.25 | I | V | G | 1489 | 563 | 2400 |
10 | Urethra | 0.25 | 0.5 | 0.008 | ≤0.016 | 0.008 | 1 | I | V | G | 5108 | 29 | 8632 |
11 | Urethra | 0.25 | 0.5 | 0.016 | ≤0.016 | 0.008 | 0.5 | I | V | G | 908 | 29 | 3935 |
12 | Urethra | 0.5 | 1 | 0.016 | ≤0.016 | 0.008 | 1 | I | V | G | 908 | 29 | 3935 |
13 | Urethra | 0.25 | 8 | 0.004 | ≤0.016 | ≤0.002 | 0.06 | I | V | G | 2649 | 1066 | 5083 |
14 | Urethra | 0.12 | 0.5 | 0.008 | ≤0.016 | ≤0.002 | 0.25 | I | V | G | 1808 | 29 | 2992 |
15 | Urethra | 0.5 | 0.5 | 0.012 | ≤0.016 | 0.008 | 1 | I | V | G | 908 | 29 | 3935 |
16 | Urethra | 0.25 | 0.5 | 0.008 | ≤0.016 | 0.016 | 1 | I | V | G | 908 | 29 | 3935 |
17 | Urethra | 1 | 0.25 | 0.008 | ≤0.016 | 4 | 0.25 | I | V | G | 2852 | 25 | 4709 |
18 | Cervix | 1 | 0.25 | 0.008 | ≤0.016 | 4 | 0.25 | I | V | G | 2852 | 25 | 4709 |
19 | Urethra | 1 | 0.5 | 0.016 | ≤0.016 | 4 | 0.5 | I | V | G | 2852 | 25 | 4709 |
20 | Urethra | 1 | 1 | 0.016 | ≤0.016 | 4 | 0.5 | I | V | G | 53 | 10 | 657 |
21 | Urethra | 0.5 | 1 | 0.008 | ≤0.016 | 0.008 | 1 | I | V | G | 908 | 29 | 3935 |
22 | Cervix | 0.5 | 0.5 | 0.016 | ≤0.016 | 0.016 | 1 | I | V | G | 908 | 29 | 3935 |
23 | Urethra | 0.12 | 0.12 | 0.004 | ≤0.016 | 0.002 | 0.12 | I | V | G | 2155 | 16 | 3556 |
24 | Urethra | 0.12 | 0.25 | 0.004 | ≤0.016 | 0.004 | 0.125 | I | V | G | 852 | 19 | 1319 |
25 | Urethra | 0.25 | 0.5 | 0.008 | ≤0.016 | 0.008 | 0.25 | I | V | G | 1808 | 29 | 2992 |
26 | Cervix | 0.25 | 0.5 | 0.008 | ≤0.016 | 0.008 | 1 | I | V | G | 908 | 29 | 3935 |
27 | Urethra | 0.25 | 0.25 | 0.008 | ≤0.016 | 0.002 | 0.5 | I | V | G | 1808 | 29 | 2992 |
28 | Urethra | 0.03 | 0.12 | ≤0.016 | ≤0.016 | ≤0.016 | 0.12 | I | V | G | 55 | 4 | 69 |
29 | Urethra | 0.25 | 0.25 | 0.008 | ≤0.016 | 0.004 | 0.5 | I | V | G | 1808 | 29 | 2992 |
30 | Urethra | 1 | 1 | 0.03 | 0.03 | >32 | 0.12 | I | V | G | 908 | 563 | 7574 |
Samples with ESCds phenotype, related allele numbers, and sequence types are shown in bold.
Antibiotic susceptibility profiles were determined with Etest strips.
Amino acid alteration(s) in the penA gene (I312M, V316T, and G545S).
Allele number, based on the por and tbpB genes.
ST, based on NG-MAST result.